The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical knowledge on emerging medications for best patient care. This review simplifies the non-insulin treatments of diabetes with an emphasis on the cardio-renal protectants, sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1).
Keywords: diabetes mellitus type 2; glucagon-like peptide 1 receptor agonists; sodium-glucose cotransporter 2.
© 2022 Justin T. Call et al., published by Sciendo.